These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16638930)
21. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Jourdan M; Veyrune JL; De Vos J; Redal N; Couderc G; Klein B Oncogene; 2003 May; 22(19):2950-9. PubMed ID: 12771946 [TBL] [Abstract][Full Text] [Related]
22. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma. Younes M; Georgakis GV; Rahmani M; Beer D; Younes A Eur J Cancer; 2006 Mar; 42(4):542-7. PubMed ID: 16426839 [TBL] [Abstract][Full Text] [Related]
23. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. Lamothe B; Aggarwal BB J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810 [TBL] [Abstract][Full Text] [Related]
25. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Puthier D; Derenne S; Barillé S; Moreau P; Harousseau JL; Bataille R; Amiot M Br J Haematol; 1999 Nov; 107(2):392-5. PubMed ID: 10583232 [TBL] [Abstract][Full Text] [Related]
26. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation. Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934 [TBL] [Abstract][Full Text] [Related]
27. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism. Pei XY; Dai Y; Grant S Mol Cancer Ther; 2004 Dec; 3(12):1513-24. PubMed ID: 15634644 [TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911 [TBL] [Abstract][Full Text] [Related]
29. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor. Muto A; Hori M; Sasaki Y; Saitoh A; Yasuda I; Maekawa T; Uchida T; Asakura K; Nakazato T; Kaneda T; Kizaki M; Ikeda Y; Yoshida T Mol Cancer Ther; 2007 Mar; 6(3):987-94. PubMed ID: 17363492 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL. Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767 [TBL] [Abstract][Full Text] [Related]
31. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
32. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836 [TBL] [Abstract][Full Text] [Related]
33. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781 [TBL] [Abstract][Full Text] [Related]
34. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Guo F; Sigua C; Tao J; Bali P; George P; Li Y; Wittmann S; Moscinski L; Atadja P; Bhalla K Cancer Res; 2004 Apr; 64(7):2580-9. PubMed ID: 15059915 [TBL] [Abstract][Full Text] [Related]
35. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365 [TBL] [Abstract][Full Text] [Related]
36. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L). Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339 [TBL] [Abstract][Full Text] [Related]
37. TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies. MacFarlane M; Kohlhaas SL; Sutcliffe MJ; Dyer MJ; Cohen GM Cancer Res; 2005 Dec; 65(24):11265-70. PubMed ID: 16357130 [TBL] [Abstract][Full Text] [Related]
38. Hypoxic switch in mitochondrial myeloid cell leukemia factor-1/Mtd apoptotic rheostat contributes to human trophoblast cell death in preeclampsia. Soleymanlou N; Jurisicova A; Wu Y; Chijiiwa M; Ray JE; Detmar J; Todros T; Zamudio S; Post M; Caniggia I Am J Pathol; 2007 Aug; 171(2):496-506. PubMed ID: 17600131 [TBL] [Abstract][Full Text] [Related]
39. Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways. Berg D; Stühmer T; Siegmund D; Müller N; Giner T; Dittrich-Breiholz O; Kracht M; Bargou R; Wajant H FEBS J; 2009 Dec; 276(23):6912-27. PubMed ID: 19895579 [TBL] [Abstract][Full Text] [Related]